BIO Stock Overview
Biogena Group Invest AG engages in the provision of dietary supplements.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Biogena Group Invest Ag Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €2.22 |
52 Week High | €2.78 |
52 Week Low | €1.53 |
Beta | 0 |
1 Month Change | 7.77% |
3 Month Change | 18.72% |
1 Year Change | -13.95% |
3 Year Change | -44.08% |
5 Year Change | n/a |
Change since IPO | -43.08% |
Recent News & Updates
Recent updates
Shareholder Returns
BIO | AT Personal Products | AT Market | |
---|---|---|---|
7D | -5.9% | 4.8% | 1.5% |
1Y | -14.0% | -2.8% | 3.5% |
Return vs Industry: BIO underperformed the Austrian Personal Products industry which returned -2.8% over the past year.
Return vs Market: BIO underperformed the Austrian Market which returned 3.5% over the past year.
Price Volatility
BIO volatility | |
---|---|
BIO Average Weekly Movement | 11.4% |
Personal Products Industry Average Movement | 4.7% |
Market Average Movement | 3.3% |
10% most volatile stocks in AT Market | 5.2% |
10% least volatile stocks in AT Market | 1.6% |
Stable Share Price: BIO's share price has been volatile over the past 3 months.
Volatility Over Time: BIO's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Austrian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | n/a | biogenagroup.com |
Biogena Group Invest AG engages in the provision of dietary supplements. The company is based in Salzburg, Austria.
Biogena Group Invest Ag Fundamentals Summary
BIO fundamental statistics | |
---|---|
Market cap | €8.86m |
Earnings (TTM) | €0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs BIO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BIO income statement (TTM) | |
---|---|
Revenue | €0 |
Cost of Revenue | €0 |
Gross Profit | €0 |
Other Expenses | €0 |
Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did BIO perform over the long term?
See historical performance and comparison